Home/Pipeline/Cardiovascular Treatments

Cardiovascular Treatments

Heart Disease

Phase 2/3Active

Key Facts

Indication
Heart Disease
Phase
Phase 2/3
Status
Active
Company

About Pfizer

Founded in 1849, Pfizer has evolved into a global biopharmaceutical leader with a comprehensive portfolio spanning vaccines, oncology treatments, and medicines for chronic diseases. The company operates extensive R&D programs across four key therapeutic areas and maintains a robust clinical pipeline with programs in all phases of development. Led by CEO Albert Bourla, Pfizer continues to drive innovation through strategic partnerships and significant investments in breakthrough science.

View full company profile